Postexposure Prophylactic Effect of Hepatitis B Virus (HBV)-Active Antiretroviral Therapy against HBV Infection

Retrospective study indicates that hepatitis B virus (HBV)-active nucleoside (nucleotide) analogues (NAs) used for antiretroviral therapy reduce the incidence of acute HBV infections in human immunodeficiency virus (HIV)-infected patients. Learning from HIV postexposure prophylaxis (PEP), we explore...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Watanabe, Tsunamasa, Hamada-Tsutsumi, Susumu, Yokomaku, Yoshiyuki, Imamura, Junji, Sugiura, Wataru, Tanaka, Yasuhito
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335850/
https://ncbi.nlm.nih.gov/pubmed/25512419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04459-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars